Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Larrimore Ouellette

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|May 10, 2017
Who reads patents?Lisa Larrimore Ouellette
Nature Nanotechnology|December 6, 2012
Nanotechnology patents are useful but could be improvedLisa Larrimore Ouellette
JAMA Internal Medicine|January 4, 2018
Selling Patents to Indian Tribes to Delay the Market Entry of Generic DrugsGregory Ablavsky, Lisa Larrimore Ouellette
Science (New York, N.Y.)|June 15, 2019
Science fiction: Fictitious experiments in patentsJanet Freilich, Lisa Larrimore Ouellette
JAMA Health Forum|November 1, 2024
Using Bayh-Dole Act March-In Rights to Lower US Drug PricesLisa Larrimore Ouellette, Bhaven N Sampat
Science (New York, N.Y.)|December 7, 2023
Improving equity in patent inventorshipColleen V Chien, Lisa Larrimore Ouellette
Journal of Law and the Biosciences|August 1, 2020
Innovation policy and the market for vaccinesQiwei Claire Xue, Lisa Larrimore Ouellette
Science (New York, N.Y.)|February 1, 2014
Research tax credits: an important toolDaniel J Hemel, Lisa Larrimore Ouellette
Journal of Law and the Biosciences|July 5, 2021
Innovation institutions and the opioid crisisDaniel J Hemel, Lisa Larrimore Ouellette
AEA Papers and Proceedings. American Economic Association|August 13, 2021
Private and Public Investments in Biomedical ResearchMaya Durvasula, Lisa Larrimore Ouellette, Heidi Williams
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|May 10, 2017
Who reads patents?Lisa Larrimore Ouellette
Nature Nanotechnology|December 6, 2012
Nanotechnology patents are useful but could be improvedLisa Larrimore Ouellette
JAMA Internal Medicine|January 4, 2018
Selling Patents to Indian Tribes to Delay the Market Entry of Generic DrugsGregory Ablavsky, Lisa Larrimore Ouellette
Science (New York, N.Y.)|June 15, 2019
Science fiction: Fictitious experiments in patentsJanet Freilich, Lisa Larrimore Ouellette
JAMA Health Forum|November 1, 2024
Using Bayh-Dole Act March-In Rights to Lower US Drug PricesLisa Larrimore Ouellette, Bhaven N Sampat
Science (New York, N.Y.)|December 7, 2023
Improving equity in patent inventorshipColleen V Chien, Lisa Larrimore Ouellette
Journal of Law and the Biosciences|August 1, 2020
Innovation policy and the market for vaccinesQiwei Claire Xue, Lisa Larrimore Ouellette
Science (New York, N.Y.)|February 1, 2014
Research tax credits: an important toolDaniel J Hemel, Lisa Larrimore Ouellette
Journal of Law and the Biosciences|July 5, 2021
Innovation institutions and the opioid crisisDaniel J Hemel, Lisa Larrimore Ouellette
AEA Papers and Proceedings. American Economic Association|August 13, 2021
Private and Public Investments in Biomedical ResearchMaya Durvasula, Lisa Larrimore Ouellette, Heidi Williams
Pageof 2